obesity drug news today glp-1 2025 oct 27 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits What Happens When Patients Stop

Mol Omics

Association of nonalcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients

Early studies suggested that GLP-1 receptor agonists might increase the risk of thyroid cancer

Under these circumstances, the bacteria translocated from the intestine into either the portal or lymphatic circulations may be transported to multiple organs

Neuroinflammation and glial cell activation in mental disorders

Patients should be educated about serious adverse effects requiring immediate medical attention, including: Pancreatitis: severe abdominal pain radiating to the back, persistent vomiting Hypersensitivity reactions: rash, difficulty breathing, facial swelling Gallbladder disease: right upper quadrant pain, fever, jaundice Thyroid C-cell tumors (boxed warning): neck mass, dysphagia, hoarseness, persistent dyspnea Regular follow-up with healthcare providers ensures appropriate monitoring and timely intervention if adverse effects occur